Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Becton, Dickinson and Company

Market Cap 39.67B 34.61B 32.03B 30.05B 56.22B 3,741B 56.61B 380B 147B 1,842B 149B 146B 6,401B P/E 2026 *
35.9x
P/E 2027 * 27.7x
Enterprise Value 55.63B 48.53B 44.91B 42.13B 78.84B 5,246B 79.37B 533B 206B 2,582B 209B 204B 8,975B EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.73x
Free-Float
74.04%
Yield 2026 *
2.67%
Yield 2027 * 2.72%
1 day+1.34%
1 week-3.10%
Current month-1.65%
1 month-1.34%
3 months-8.09%
6 months-24.33%
Current year-24.55%
1 week 123.25
Extreme 123.25
126.7
1 month 123.25
Extreme 123.25
132.05
Current year 121
Extreme 121
179
1 year 121
Extreme 121
179
3 years 121
Extreme 121
261
5 years 121
Extreme 121
265
10 years 121
Extreme 121
265
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.34%-3.10% - - 39.67B
-0.10%+0.26%-33.52%-17.14% 154B
+1.54%-1.07%-8.11%-10.79% 102B
-4.45%+3.12%+61.36%+57.49% 56.51B
-1.90%-3.49%-7.43%+47.34% 52.89B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-9.41%-44.24% 27.96B
+1.35%-0.26%+51.96%-10.42% 23.17B
-1.53%+1.14%-15.21%-5.72% 20.35B
+1.61%-2.38%-14.03%-5.14% 19.75B
Average -0.17%-1.29%+3.20%+1.42% 54.06B
Weighted average by Cap. -0.22%-1.19%-5.61%+0.70%

Financials

2026 *2027 *
Net sales 19.21B 16.75B 15.5B 14.55B 27.22B 1,811B 27.4B 184B 71.19B 891B 72.08B 70.54B 3,099B 19.71B 17.19B 15.91B 14.93B 27.93B 1,859B 28.12B 189B 73.07B 915B 73.98B 72.39B 3,180B
Net income 1.12B 981M 908M 852M 1.59B 106B 1.6B 10.77B 4.17B 52.2B 4.22B 4.13B 181B 1.45B 1.26B 1.17B 1.1B 2.05B 137B 2.07B 13.88B 5.37B 67.27B 5.44B 5.32B 234B
Net Debt 15.95B 13.92B 12.88B 12.08B 22.61B 1,505B 22.77B 153B 59.14B 741B 59.89B 58.6B 2,574B 14.07B 12.28B 11.36B 10.66B 19.94B 1,327B 20.08B 135B 52.16B 653B 52.82B 51.69B 2,271B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
19/06/26 124.90 +1.34% 0
18/06/26 123.25 -0.32% 0
17/06/26 123.65 -1.47% 122
16/06/26 125.50 -0.95% 37
15/06/26 126.70 -1.71% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
143.98USD
Average target price
180.69USD
Spread / Average Target
+25.50%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!